Holen Sie sich die Stockscreener-App
6.58
4.28%
0.27
Vorhandelsmarkt:
6.60
0.02
+0.30%
Schlusskurs vom Vortag:
$6.31
Offen:
$6.38
24-Stunden-Volumen:
1.55M
Relative Volume:
1.58
Marktkapitalisierung:
$773.69M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-174.61M
KGV:
-3.3401
EPS:
-1.97
Netto-Cashflow:
$-165.54M
1W Leistung:
+4.78%
1M Leistung:
-17.13%
6M Leistung:
-21.20%
1J Leistung:
-40.40%
1-Tages-Spanne:
$6.335
$6.61
1-Wochen-Bereich:
$5.9857
$6.65
52-Wochen-Spanne:
$5.9857
$16.63
89 Bio Inc Stock (ETNB) Company Profile
Firmenname
89 Bio Inc
Sektor
Branche
Telefon
(415) 432-9270
Adresse
142 SANSOME STREET, SAN FRANCISCO, CA
Vergleichen Sie ETNB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
6.58 | 773.69M | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-22 | Fortgesetzt | BofA Securities | Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-08-28 | Eingeleitet | UBS | Buy |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2022-05-12 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-26 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-29 | Fortgesetzt | BTIG Research | Buy |
| 2021-05-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-19 | Eingeleitet | Raymond James | Strong Buy |
| 2020-09-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-23 | Eingeleitet | BTIG Research | Buy |
| 2020-07-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-12-09 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-12-09 | Eingeleitet | Oppenheimer | Outperform |
| 2019-12-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-12-09 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
89 Bio Inc Aktie (ETNB) Neueste Nachrichten
89bio shares maintain Buy rating as analyst cites confidence in pegozafermin trial outcomes - MSN
HC Wainwright Reiterates Buy Rating for 89bio (NASDAQ:ETNB) - MarketBeat
Weiss Ratings Reiterates Sell (D-) Rating for 89bio (NASDAQ:ETNB) - MarketBeat
Hennion & Walsh Asset Management Inc. Takes $739,000 Position in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
89bio (NASDAQ: ETNB) Provides Corporate Update and Business Outlook for 2025SAN FRANCISCO, January 13, 2025 (GLOBE NEWSWIRE) – 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company specializing in innovative therapies for l - Defense World
Weiss Ratings Reiterates “Sell (D-)” Rating for 89bio (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Short Interest Up 12.2% in December - MarketBeat
89bio (NASDAQ:ETNB) Hits New 12-Month Low After Insider Selling - Defense World
89bio, Inc. (NASDAQ:ETNB) Insider Sells $71,149.87 in Stock - MarketBeat
89bio's chief technical operations officer sells $71,149 in stock - MSN
89bio's chief technical operations officer sells $71,149 in stock By Investing.com - Investing.com South Africa
89bio (NASDAQ:ETNB) Stock Price Down 4%Time to Sell? - MarketBeat
89bio (NASDAQ:ETNB) Reaches New 12-Month LowTime to Sell? - MarketBeat
89bio: Advancement Of Pegozafermin For SHTG Is Another Path Forward (NASDAQ:ETNB) - Seeking Alpha
89bio Provides Business Update and Outlook for 2025 - The Manila Times
89bio Completes Phase 3 Trial Enrollment, Fortifies Position with $440M Cash Reserve - StockTitan
89bio (NASDAQ:ETNB) Sets New 1-Year Low – Should You Sell? - Defense World
89bio, Inc. (NASDAQ:ETNB) Shares Acquired by Barclays PLC - MarketBeat
Barclays PLC Acquires 149,479 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Certain Warrant of 89bio, Inc. are subject to a Lock-Up Agreement Ending on 12-JAN-2025. - Marketscreener.com
89bio (NASDAQ:ETNB) Hits New 52-Week LowHere's Why - MarketBeat
89bio stock hits 52-week low at $6.42 amid market challenges By Investing.com - Investing.com South Africa
89bio stock hits 52-week low at $6.42 amid market challenges - Investing.com Australia
89bio (NASDAQ:ETNB) Stock Price Down 8.2%Here's What Happened - MarketBeat
Rare Endocrinology and Metabolic Disorders Market Analysis: Emerging Trends and Future Outlook of Hypophosphatasia, Congenital Adrenal Hyperplasia, and Severe Hypertriglyceridemia | DelveInsight - GlobeNewswire Inc.
Non-Alcoholic Steatohepatitis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Madrigal Pharmac, Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Viking - The Globe and Mail
Biotech manufacturer plans to cut 120 jobs in Durham - WRAL News
Brokerages Set 89bio, Inc. (NASDAQ:ETNB) PT at $30.33 - Defense World
89bio's SWOT analysis: pegozafermin potential drives stock outlook By Investing.com - Investing.com Australia
89bio (NASDAQ:ETNB) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World
89bio’s SWOT analysis: pegozafermin potential drives stock outlook By Investing.com - Investing.com Nigeria
89bio's SWOT analysis: pegozafermin potential drives stock outlook - Investing.com India
89bio (NASDAQ:ETNB) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
89bio, Inc. (NASDAQ:ETNB) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Head to Head Review: VectivBio (NASDAQ:VECT) versus Tourmaline Bio (NASDAQ:TRML) - Defense World
89bio (NASDAQ:ETNB) Stock Price Down 3.7%Should You Sell? - MarketBeat
Jane Street Group LLC Has $1.03 Million Stock Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Jane Street Group LLC Has $1.03 Million Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
89bio, Inc. (NASDAQ:ETNB) Shares Purchased by Geode Capital Management LLC - Defense World
Geode Capital Management LLC Has $15.36 Million Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
Barclays PLC Boosts Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Barclays PLC Raises Stock Position in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
89bio, Inc. (NASDAQ:ETNB) Holdings Reduced by Franklin Resources Inc. - MarketBeat
89bio Grants Retention RSUs to Key Officers - Defense World
State Street Corp Acquires 7,184 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio (NASDAQ:ETNB) Sets New 52-Week Low – Here’s Why - Defense World
89bio (NASDAQ:ETNB) Sets New 52-Week LowHere's Why - MarketBeat
89bio stock hits 52-week low at $6.96 amid market challenges - Investing.com Canada
Finanzdaten der 89 Bio Inc-Aktie (ETNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):